FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3287111000001103: Aminophylline hydrate 225mg modified-release tablets 56 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22370501000001117 Aminophylline hydrate 225mg modified-release tablets 56 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22370601000001118 Aminophylline hydrate 225mg modified-release tablets 56 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aminophylline hydrate 225mg modified-release tablets 56 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Aminophylline hydrate 225mg modified-release tablets 56 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Aminophylline hydrate 225mg modified-release tablets 56 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Aminophylline hydrate 225mg modified-release tablets 56 tablet Is pack of Aminophylline hydrate 225mg modified-release tablet false Inferred relationship Existential restriction modifier
Aminophylline hydrate 225mg modified-release tablets 56 tablet Has active ingredient Musculoskeletal system agent false Inferred relationship Existential restriction modifier
Aminophylline hydrate 225mg modified-release tablets 56 tablet Has active ingredient Aminophylline false Inferred relationship Existential restriction modifier
Aminophylline hydrate 225mg modified-release tablets 56 tablet Has active ingredient Substance with phosphodiesterase inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Aminophylline hydrate 225mg modified-release tablets 56 tablet Has active ingredient Aminophylline hydrate false Inferred relationship Existential restriction modifier
Aminophylline hydrate 225mg modified-release tablets 56 tablet VMP prescribing status (attribute) Not recommended to prescribe as a VMP false Inferred relationship Existential restriction modifier
Aminophylline hydrate 225mg modified-release tablets 56 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Aminophylline hydrate 225mg modified-release tablets 56 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Aminophylline hydrate 225mg modified-release tablets 56 tablet Is pack of Aminophylline hydrate 225mg modified-release tablets false Inferred relationship Existential restriction modifier
Aminophylline hydrate 225mg modified-release tablets 56 tablet Has VMP Aminophylline hydrate 225mg modified-release tablets true Inferred relationship Existential restriction modifier
Aminophylline hydrate 225mg modified-release tablets 56 tablet Has specific active ingredient Aminophylline hydrate true Inferred relationship Existential restriction modifier
Aminophylline hydrate 225mg modified-release tablets 56 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Aminophylline hydrate 225mg modified-release tablets 56 tablet VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Aminophylline hydrate 225mg modified-release tablets 56 tablet VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Is a True Aminophylline hydrate 225mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier
Aminophylline hydrate 225mg modified-release tablets (Colorama Pharmaceuticals Ltd) 56 tablet Is a False Aminophylline hydrate 225mg modified-release tablets 56 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start